RIFM increases transparency
This article was originally published in The Rose Sheet
Executive SummaryThe Research Institute for Fragrance Materials is opening its Expert Panel review process to the public "in alignment with the fragrance industry's move towards greater transparency about its ingredients," says the scientific arm of the International Fragrance Association April 2. The move should "emphasize the credibility of its scientific methodology," according to the release. In an effort to enhance dialogue in the fragrance community, the organization is requesting information on fragrance materials in advance of meetings. The panel expects to next meet in early May to discuss macrocyclic lactones and lactides, macrocyclic ketones and ketones cyclopentanone and cyclopentenone. Information on the compounds will be accepted through April 16 and compiled as background to inform panel's discussion, RIFM says. Requests to personally present information at the meeting also will be considered
You may also be interested in...
Updated data from a postmarket study of Abiomed’s Impella RP right-heart pump further supports the device’s safety for a specific patient population.
The new US-Mexico-Canada (USMCA) trade agreement includes language on enhancing regulatory compatibility between the three countries by recognizing quality systems audits performed under the Medical Device Single Audit Program (MDSAP). It also stipulates that each trading partner “consider its resources and technical capacity” in ensuring the safety, effectiveness and quality of devices – and more. Medtech industry advocacy group AdvaMed is praising the deal, reached by the three countries on 10 December.